MCID: MSC046
MIFTS: 24

Muscular Dystrophy-Dystroglycanopathy , Type B, 3

Categories: Genetic diseases, Neuronal diseases, Muscle diseases, Mental diseases, Eye diseases, Metabolic diseases, Fetal diseases, Rare diseases

Aliases & Classifications for Muscular Dystrophy-Dystroglycanopathy , Type B, 3

MalaCards integrated aliases for Muscular Dystrophy-Dystroglycanopathy , Type B, 3:

Name: Muscular Dystrophy-Dystroglycanopathy , Type B, 3 57 13 73
Congenital Muscular Dystrophy-Dystroglycanopathy with Mental Retardation, Type B3 29 6
Mddgb3 57 75
Muscular Dystrophy-Dystroglycanopathy Congenital with Mental Retardation B3 75
Muscular Dystrophy, Congenital, Pomgnt1-Related 57
Muscular Dystrophy Congenital Pomgnt1-Related 75

Characteristics:

OMIM:

57
Inheritance:
autosomal recessive

Miscellaneous:
onset at birth
two unrelated patients have been reported


HPO:

32
muscular dystrophy-dystroglycanopathy , type b, 3:
Onset and clinical course congenital onset
Inheritance autosomal recessive inheritance


Classifications:



Summaries for Muscular Dystrophy-Dystroglycanopathy , Type B, 3

OMIM : 57 MDDGB3 is an autosomal recessive congenital muscular dystrophy with mental retardation and mild brain abnormalities (Clement et al., 2008). It is part of a group of similar disorders resulting from defective glycosylation of alpha-dystroglycan (DAG1; 128239), collectively known as 'dystroglycanopathies' (Mercuri et al., 2009). For a discussion of genetic heterogeneity of congenital muscular dystrophy-dystroglycanopathy type B, see MDDGB1 (613155). (613151)

MalaCards based summary : Muscular Dystrophy-Dystroglycanopathy , Type B, 3, is also known as congenital muscular dystrophy-dystroglycanopathy with mental retardation, type b3. An important gene associated with Muscular Dystrophy-Dystroglycanopathy , Type B, 3 is POMGNT1 (Protein O-Linked Mannose N-Acetylglucosaminyltransferase 1 (Beta 1,2-)). Affiliated tissues include brain and pons, and related phenotypes are microcephaly and strabismus

UniProtKB/Swiss-Prot : 75 Muscular dystrophy-dystroglycanopathy congenital with mental retardation B3: An autosomal recessive disorder characterized by congenital muscular dystrophy associated with mental retardation and mild structural brain abnormalities. Clinical features include mental retardation, white matter changes, cerebellar cysts, pontine hypoplasia, myopia, optic atrophy, decreased alpha-dystroglycan on muscle biopsy and increased serum creatine kinase.

Related Diseases for Muscular Dystrophy-Dystroglycanopathy , Type B, 3

Diseases in the Muscular Dystrophy-Dystroglycanopathy family:

Muscular Dystrophy-Dystroglycanopathy , Type a, 1 Muscular Dystrophy-Dystroglycanopathy , Type a, 3
Muscular Dystrophy-Dystroglycanopathy , Type a, 4 Muscular Dystrophy-Dystroglycanopathy , Type B, 5
Muscular Dystrophy-Dystroglycanopathy , Type C, 5 Muscular Dystrophy-Dystroglycanopathy , Type B, 6
Muscular Dystrophy-Dystroglycanopathy , Type C, 1 Muscular Dystrophy-Dystroglycanopathy , Type C, 4
Muscular Dystrophy-Dystroglycanopathy , Type a, 2 Muscular Dystrophy-Dystroglycanopathy , Type B, 3
Muscular Dystrophy-Dystroglycanopathy , Type B, 4 Muscular Dystrophy-Dystroglycanopathy , Type a, 5
Muscular Dystrophy-Dystroglycanopathy , Type a, 6 Muscular Dystrophy-Dystroglycanopathy , Type B, 1
Muscular Dystrophy-Dystroglycanopathy , Type B, 2 Muscular Dystrophy-Dystroglycanopathy , Type C, 3
Muscular Dystrophy-Dystroglycanopathy , Type C, 2 Muscular Dystrophy-Dystroglycanopathy , Type C, 9
Muscular Dystrophy-Dystroglycanopathy , Type a, 7 Muscular Dystrophy-Dystroglycanopathy , Type a, 8
Muscular Dystrophy-Dystroglycanopathy , Type a, 10 Muscular Dystrophy-Dystroglycanopathy , Type a, 11
Muscular Dystrophy-Dystroglycanopathy , Type a, 12 Muscular Dystrophy-Dystroglycanopathy , Type a, 13
Muscular Dystrophy-Dystroglycanopathy , Type a, 14 Muscular Dystrophy-Dystroglycanopathy , Type B, 14
Muscular Dystrophy-Dystroglycanopathy , Type C, 14 Muscular Dystrophy-Dystroglycanopathy , Type C, 7
Muscular Dystrophy-Dystroglycanopathy , Type C, 12 Muscular Dystrophy-Dystroglycanopathy , Type a, 9

Symptoms & Phenotypes for Muscular Dystrophy-Dystroglycanopathy , Type B, 3

Symptoms via clinical synopsis from OMIM:

57
Head And Neck Head:
microcephaly

Neurologic Central Nervous System:
cerebellar hypoplasia
delayed motor development
mental retardation
ventricular dilatation
pontine hypoplasia
more
Laboratory Abnormalities:
increased serum creatine kinase

Head And Neck Eyes:
optic atrophy
strabismus
myopia

Muscle Soft Tissue:
muscular dystrophy
muscle biopsy shows decreased glycosylation of alpha-dystroglycan (dag1, )


Clinical features from OMIM:

613151

Human phenotypes related to Muscular Dystrophy-Dystroglycanopathy , Type B, 3:

32 (show all 13)
# Description HPO Frequency HPO Source Accession
1 microcephaly 32 HP:0000252
2 strabismus 32 HP:0000486
3 myopia 32 HP:0000545
4 optic atrophy 32 HP:0000648
5 intellectual disability 32 HP:0001249
6 motor delay 32 HP:0001270
7 cerebellar hypoplasia 32 HP:0001321
8 ventriculomegaly 32 HP:0002119
9 cerebellar cyst 32 HP:0002350
10 elevated serum creatine phosphokinase 32 HP:0003236
11 muscular dystrophy 32 HP:0003560
12 congenital muscular dystrophy 32 HP:0003741
13 hypoplasia of the pons 32 HP:0012110

Drugs & Therapeutics for Muscular Dystrophy-Dystroglycanopathy , Type B, 3

Search Clinical Trials , NIH Clinical Center for Muscular Dystrophy-Dystroglycanopathy , Type B, 3

Genetic Tests for Muscular Dystrophy-Dystroglycanopathy , Type B, 3

Genetic tests related to Muscular Dystrophy-Dystroglycanopathy , Type B, 3:

# Genetic test Affiliating Genes
1 Congenital Muscular Dystrophy-Dystroglycanopathy with Mental Retardation, Type B3 29 POMGNT1

Anatomical Context for Muscular Dystrophy-Dystroglycanopathy , Type B, 3

MalaCards organs/tissues related to Muscular Dystrophy-Dystroglycanopathy , Type B, 3:

41
Brain, Pons

Publications for Muscular Dystrophy-Dystroglycanopathy , Type B, 3

Variations for Muscular Dystrophy-Dystroglycanopathy , Type B, 3

UniProtKB/Swiss-Prot genetic disease variations for Muscular Dystrophy-Dystroglycanopathy , Type B, 3:

75
# Symbol AA change Variation ID SNP ID
1 POMGNT1 p.Arg311Gln VAR_023104 rs193919336
2 POMGNT1 p.Cys490Tyr VAR_023107 rs267606960
3 POMGNT1 p.Arg605Pro VAR_065026 rs267606962

ClinVar genetic disease variations for Muscular Dystrophy-Dystroglycanopathy , Type B, 3:

6
(show top 50) (show all 88)
# Gene Variation Type Significance SNP ID Assembly Location
1 POMGNT1 NM_001243766.1(POMGNT1): c.1814G> C (p.Arg605Pro) single nucleotide variant Pathogenic rs267606962 GRCh37 Chromosome 1, 46655211: 46655211
2 POMGNT1 NM_001243766.1(POMGNT1): c.1814G> C (p.Arg605Pro) single nucleotide variant Pathogenic rs267606962 GRCh38 Chromosome 1, 46189539: 46189539
3 POMGNT1 NM_017739.3(POMGNT1): c.652+1G> A single nucleotide variant Pathogenic/Likely pathogenic rs386834035 GRCh38 Chromosome 1, 46194843: 46194843
4 POMGNT1 NM_017739.3(POMGNT1): c.652+1G> A single nucleotide variant Pathogenic/Likely pathogenic rs386834035 GRCh37 Chromosome 1, 46660515: 46660515
5 POMGNT1 NM_017739.3(POMGNT1): c.1469G> A (p.Cys490Tyr) single nucleotide variant Likely pathogenic rs267606960 GRCh37 Chromosome 1, 46657840: 46657840
6 POMGNT1 NM_017739.3(POMGNT1): c.1469G> A (p.Cys490Tyr) single nucleotide variant Likely pathogenic rs267606960 GRCh38 Chromosome 1, 46192168: 46192168
7 POMGNT1 NM_017739.3(POMGNT1): c.1539+1G> A single nucleotide variant Pathogenic rs138642840 GRCh37 Chromosome 1, 46657769: 46657769
8 POMGNT1 NM_017739.3(POMGNT1): c.1539+1G> A single nucleotide variant Pathogenic rs138642840 GRCh38 Chromosome 1, 46192097: 46192097
9 POMGNT1 NM_017739.3(POMGNT1): c.643C> T (p.Arg215Ter) single nucleotide variant Pathogenic rs386834034 GRCh37 Chromosome 1, 46660525: 46660525
10 POMGNT1 NM_017739.3(POMGNT1): c.643C> T (p.Arg215Ter) single nucleotide variant Pathogenic rs386834034 GRCh38 Chromosome 1, 46194853: 46194853
11 POMGNT1 NM_017739.3(POMGNT1): c.1298C> T (p.Thr433Met) single nucleotide variant Conflicting interpretations of pathogenicity rs146097254 GRCh38 Chromosome 1, 46192423: 46192423
12 POMGNT1 NM_017739.3(POMGNT1): c.1298C> T (p.Thr433Met) single nucleotide variant Conflicting interpretations of pathogenicity rs146097254 GRCh37 Chromosome 1, 46658095: 46658095
13 POMGNT1 NM_017739.3(POMGNT1): c.319C> A (p.Arg107Ser) single nucleotide variant Uncertain significance rs375420073 GRCh38 Chromosome 1, 46196766: 46196766
14 POMGNT1 NM_017739.3(POMGNT1): c.319C> A (p.Arg107Ser) single nucleotide variant Uncertain significance rs375420073 GRCh37 Chromosome 1, 46662438: 46662438
15 POMGNT1 NM_017739.3(POMGNT1): c.421-7C> A single nucleotide variant Conflicting interpretations of pathogenicity rs189274856 GRCh37 Chromosome 1, 46661603: 46661603
16 POMGNT1 NM_017739.3(POMGNT1): c.421-7C> A single nucleotide variant Conflicting interpretations of pathogenicity rs189274856 GRCh38 Chromosome 1, 46195931: 46195931
17 POMGNT1 NM_017739.3(POMGNT1): c.1510G> A (p.Val504Ile) single nucleotide variant Conflicting interpretations of pathogenicity rs17102066 GRCh37 Chromosome 1, 46657799: 46657799
18 POMGNT1 NM_017739.3(POMGNT1): c.1510G> A (p.Val504Ile) single nucleotide variant Conflicting interpretations of pathogenicity rs17102066 GRCh38 Chromosome 1, 46192127: 46192127
19 POMGNT1 NM_017739.3(POMGNT1): c.1979C> T (p.Thr660Ile) single nucleotide variant Uncertain significance rs377760450 GRCh37 Chromosome 1, 46654946: 46654946
20 POMGNT1 NM_017739.3(POMGNT1): c.1979C> T (p.Thr660Ile) single nucleotide variant Uncertain significance rs377760450 GRCh38 Chromosome 1, 46189274: 46189274
21 POMGNT1 NM_017739.3(POMGNT1): c.706G> C (p.Asp236His) single nucleotide variant Uncertain significance rs201525710 GRCh37 Chromosome 1, 46660270: 46660270
22 POMGNT1 NM_017739.3(POMGNT1): c.706G> C (p.Asp236His) single nucleotide variant Uncertain significance rs201525710 GRCh38 Chromosome 1, 46194598: 46194598
23 POMGNT1 NM_017739.3(POMGNT1): c.46C> T (p.Arg16Trp) single nucleotide variant Uncertain significance rs34058684 GRCh37 Chromosome 1, 46663448: 46663448
24 POMGNT1 NM_017739.3(POMGNT1): c.46C> T (p.Arg16Trp) single nucleotide variant Uncertain significance rs34058684 GRCh38 Chromosome 1, 46197776: 46197776
25 POMGNT1 NM_017739.3(POMGNT1): c.1457G> A (p.Arg486Gln) single nucleotide variant Uncertain significance rs753030030 GRCh37 Chromosome 1, 46657852: 46657852
26 POMGNT1 NM_017739.3(POMGNT1): c.1457G> A (p.Arg486Gln) single nucleotide variant Uncertain significance rs753030030 GRCh38 Chromosome 1, 46192180: 46192180
27 POMGNT1 NM_017739.3(POMGNT1): c.1454G> A (p.Arg485His) single nucleotide variant Uncertain significance rs544816408 GRCh37 Chromosome 1, 46657855: 46657855
28 POMGNT1 NM_017739.3(POMGNT1): c.1454G> A (p.Arg485His) single nucleotide variant Uncertain significance rs544816408 GRCh38 Chromosome 1, 46192183: 46192183
29 POMGNT1 NM_017739.3(POMGNT1): c.172A> G (p.Ile58Val) single nucleotide variant Uncertain significance rs886044042 GRCh37 Chromosome 1, 46662705: 46662705
30 POMGNT1 NM_017739.3(POMGNT1): c.172A> G (p.Ile58Val) single nucleotide variant Uncertain significance rs886044042 GRCh38 Chromosome 1, 46197033: 46197033
31 POMGNT1 NM_017739.3(POMGNT1): c.269G> A (p.Arg90His) single nucleotide variant Uncertain significance rs139701867 GRCh37 Chromosome 1, 46662488: 46662488
32 POMGNT1 NM_017739.3(POMGNT1): c.269G> A (p.Arg90His) single nucleotide variant Uncertain significance rs139701867 GRCh38 Chromosome 1, 46196816: 46196816
33 POMGNT1 NM_017739.3(POMGNT1): c.1284+9G> C single nucleotide variant Conflicting interpretations of pathogenicity rs565797493 GRCh37 Chromosome 1, 46658181: 46658181
34 POMGNT1 NM_017739.3(POMGNT1): c.1284+9G> C single nucleotide variant Conflicting interpretations of pathogenicity rs565797493 GRCh38 Chromosome 1, 46192509: 46192509
35 POMGNT1 NM_017739.3(POMGNT1): c.440G> A (p.Arg147His) single nucleotide variant Uncertain significance rs776165339 GRCh38 Chromosome 1, 46195905: 46195905
36 POMGNT1 NM_017739.3(POMGNT1): c.440G> A (p.Arg147His) single nucleotide variant Uncertain significance rs776165339 GRCh37 Chromosome 1, 46661577: 46661577
37 POMGNT1 NM_017739.3(POMGNT1): c.251G> A (p.Arg84His) single nucleotide variant Uncertain significance rs373866304 GRCh38 Chromosome 1, 46196834: 46196834
38 POMGNT1 NM_017739.3(POMGNT1): c.251G> A (p.Arg84His) single nucleotide variant Uncertain significance rs373866304 GRCh37 Chromosome 1, 46662506: 46662506
39 POMGNT1 NC_000001.11: g.(?_46188699)_(46197841_?)dup duplication Uncertain significance GRCh37 Chromosome 1, 46654371: 46663513
40 POMGNT1 NC_000001.11: g.(?_46188699)_(46197841_?)dup duplication Uncertain significance GRCh38 Chromosome 1, 46188699: 46197841
41 POMGNT1 NM_017739.3(POMGNT1): c.1509C> T (p.Ile503=) single nucleotide variant Likely benign rs370215834 GRCh37 Chromosome 1, 46657800: 46657800
42 POMGNT1 NM_017739.3(POMGNT1): c.1509C> T (p.Ile503=) single nucleotide variant Likely benign rs370215834 GRCh38 Chromosome 1, 46192128: 46192128
43 POMGNT1 NM_017739.3(POMGNT1): c.550C> T (p.His184Tyr) single nucleotide variant Uncertain significance rs746638187 GRCh37 Chromosome 1, 46660618: 46660618
44 POMGNT1 NM_017739.3(POMGNT1): c.550C> T (p.His184Tyr) single nucleotide variant Uncertain significance rs746638187 GRCh38 Chromosome 1, 46194946: 46194946
45 POMGNT1 NM_017739.3(POMGNT1): c.70A> G (p.Thr24Ala) single nucleotide variant Uncertain significance rs766907690 GRCh37 Chromosome 1, 46663424: 46663424
46 POMGNT1 NM_017739.3(POMGNT1): c.70A> G (p.Thr24Ala) single nucleotide variant Uncertain significance rs766907690 GRCh38 Chromosome 1, 46197752: 46197752
47 POMGNT1 NM_017739.3(POMGNT1): c.1110+9T> C single nucleotide variant Uncertain significance GRCh38 Chromosome 1, 46193296: 46193296
48 POMGNT1 NM_017739.3(POMGNT1): c.1110+9T> C single nucleotide variant Uncertain significance GRCh37 Chromosome 1, 46658968: 46658968
49 POMGNT1 NM_017739.3(POMGNT1): c.1014C> T (p.Asp338=) single nucleotide variant Likely benign rs780555791 GRCh37 Chromosome 1, 46659248: 46659248
50 POMGNT1 NM_017739.3(POMGNT1): c.1014C> T (p.Asp338=) single nucleotide variant Likely benign rs780555791 GRCh38 Chromosome 1, 46193576: 46193576

Expression for Muscular Dystrophy-Dystroglycanopathy , Type B, 3

Search GEO for disease gene expression data for Muscular Dystrophy-Dystroglycanopathy , Type B, 3.

Pathways for Muscular Dystrophy-Dystroglycanopathy , Type B, 3

GO Terms for Muscular Dystrophy-Dystroglycanopathy , Type B, 3

Sources for Muscular Dystrophy-Dystroglycanopathy , Type B, 3

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....